WELLS FARGO & COMPANY/MN - IRONWOOD PHARMACEUTICALS INC ownership

IRONWOOD PHARMACEUTICALS INC's ticker is and the CUSIP is 46333XAD0. A total of 21 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
WELLS FARGO & COMPANY/MN ownership history of IRONWOOD PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2022$5,0000.0%5,0000.0%0.00%
Q4 2021$5,000
-16.7%
5,0000.0%0.00%
Q3 2021$6,0000.0%5,0000.0%0.00%
Q2 2021$6,000
+20.0%
5,0000.0%0.00%
Q1 2021$5,0000.0%5,0000.0%0.00%
Q4 2020$5,0000.0%5,0000.0%0.00%
Q3 2020$5,0000.0%5,0000.0%0.00%
Q2 2020$5,0000.0%5,0000.0%0.00%
Q1 2020$5,000
-16.7%
5,0000.0%0.00%
Q4 2019$6,000
+20.0%
5,0000.0%0.00%
Q3 2019$5,0000.0%5,0000.0%0.00%
Q2 2019$5,0000.0%5,0000.0%0.00%
Q1 2019$5,0000.0%5,0000.0%0.00%
Q4 2018$5,000
-16.7%
5,0000.0%0.00%
Q3 2018$6,000
-14.3%
5,0000.0%0.00%
Q2 2018$7,000
+16.7%
5,0000.0%0.00%
Q1 2018$6,0000.0%5,0000.0%0.00%
Q4 2017$6,0000.0%5,0000.0%0.00%
Q3 2017$6,0000.0%5,0000.0%0.00%
Q2 2017$6,0000.0%5,0000.0%0.00%
Q1 2017$6,0000.0%5,0000.0%0.00%
Q4 2016$6,0000.0%5,0000.0%0.00%
Q3 2016$6,000
+20.0%
5,0000.0%0.00%
Q2 2016$5,0005,0000.00%
Other shareholders
IRONWOOD PHARMACEUTICALS INC shareholders Q4 2019
NameSharesValueWeighting ↓
Opti Capital Management, LP 11,901$11,946,0002.07%
Context Capital Management, LLC 1,000,000$997,0000.56%
WOLVERINE ASSET MANAGEMENT LLC 33,392,000$33,442,0000.42%
SSI INVESTMENT MANAGEMENT LLC 3,000,000$2,991,0000.22%
CSS LLC/IL 2,876,000$2,883,0000.18%
PALISADE CAPITAL MANAGEMENT, LP 5,000,000$5,016,0000.15%
HBK INVESTMENTS L P 10,116,000$10,186,0000.13%
TENOR CAPITAL MANAGEMENT Co., L.P. 1,817,000$1,835,0000.11%
LINDEN ADVISORS LP 6,269,000$6,290,0000.08%
LAZARD ASSET MANAGEMENT LLC 15,000,000$15,028,0000.02%
View complete list of IRONWOOD PHARMACEUTICALS INC shareholders